1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Anticoagulants-Competitive Landscape, & Pipeline Insights, 2015

Summary
The Report, “Anticoagulants-Competitive Landscape, & Pipeline Insights, 2015” analyzes that Anticoagulants has lot of future scope and potential in the market. Mostly anticoagulants are being used in Venous Thromboembolism and Atrial Fibrillation. There are 16 anticoagulants in pipeline for venous thromboembolism, Atrial Fibrillation, Acute Coronary Syndrome, Stroke and Myocardial Infarction.The new report analysis predicts that global VTE therapeutics market was worth USD 4 billion in 2014 and expected to reach USD 5.5 billion by 2018 with a Compound Annual Growth Rate (CAGR) of 8.29%.The report analysis forecasts that global Atrial Fibrillation market will reach on its peak value USD 13.28 billion in 2018 from USD 7.86 billion in 2014 with compound annual growth rate (CAGR) of 14%.The Anticoagulants’ market is expected to decline after 2018 as many anticoagulants are going to be generic.

Please note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated mode of therapy.

Scope
- Overview of Anticoagulants, which includes its physiology, pathophysiology, diagnosis and treatment.
- Report has covered the worldwide market of Anticoagulants, information of marketed molecules including patent expiry and detail profiling of Pipeline assets
- Anticoagulants annual sales and forecasted sales of major player still 2018
- Venous Thromboembolism and Atrial Fibrillation annual estimates and forecasts are provided along with historical analysis
- Detailed epidemiology for every region as well as trends in epidemiology and Information of Antidotes for Anticoagulants which are in pipeline
- Pipeline analysis: Comprehensive data split across different phases and emerging trends and therapeutic assessments by molecule type, route and mechanism of action
- The new Anticoagulant report includes strategic competitor assessment, market characterization, opportunities, barriers, challenges and regulatory hurdles for the Anticoagulants market.

Reasons to buy
- The Anticoagulant report covers complete Market and Pipeline intelligence and understanding over therapeutics development for Anticoagulants
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Anticoagulants
- The Anti-coagulants report helps to develop business strategies by understanding the trends shaping and driving for Anticoagulants market
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Anticoagulants pipeline in-depth
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners to enhance and expand business potential and scope
- Identifying the upcoming leaders in the Anticoagulants market in the coming years.

Table Of Contents

Anticoagulants-Competitive Landscape, and Pipeline Insights, 2015
Illustrative Table of contents

- Introduction
- Executive Summary
- Blood Coagulation
- Antithrombotic Drugs
- Antiplatelets
- Fibrinolytic Drugs
- Anticoagulants
- Classification of Anticoagulants on the basis of agents
- Active Therapy Areas for Anticoagulants
- Marketed Drugs for Anticoagulants
- List of Marketed drugs and Approval date
- List of marketed drugs along with Dosage Form and Strength
- Type of Marketed Anticoagulants
- Marketed Anticoagulants Patent Details
- Marketed anticoagulants for each Indication
- Comparative Assessment of Warfarin with Other Available AntiCoagulants
- Commercial Assessment
- Sales of Major Drugs in Market
- Forecasted Sales of Major drugs in Market
- Pipeline Drugs for Anticoagulants
- Clinical profile of Phase III pipeline molecules
- Pipeline Molecules under Development
- Pipeline drugs by Phases
- Pipeline drugs by Mechanism of Action
- Pipeline drugs by Route of Administration
- Pipeline drugs by Molecule Type
- Profile of Pipeline Drugs
- Phase III/ Late Stage Molecules
- Drug 1
- Product Description
- Research and Development
- Phase II/ Mid Stage Molecules
- Drug 2
- Product Description
- Research and Development
- Phase I/Early Stage Molecules
- Drug 3
- Product Description
- Research and Development
- Pre-Clinical Molecules
- Drug 4
- Product Description
- Research and Development
- Discovery Molecules
- Drug 5
- Product Description
- Discontinued Drugs
- Dormant Drugs
- Antidotes in pipeline for Anticoagulants:
- Prevalent Indications for Anticoagulants
- Venous Thromboembolism
- Epidemiology of Venous Thromboembolism:
- Trends in epidemiology
- Complications
- Diagnosis of Venous Thromboembolism
- Pathophysiology of Venous Thromboembolism
- Current and future market of Venous Thromboembolism
- Competition and Unmet Need of Venous Thromboembolism market
- Atrial Fibrillation
- Epidemiology of Atrial Fibrillation (AF)
- Diagnosis of Atrial Fibrillation (AF)
-Complications
- Treatment for Atrial Fibrillation
- Current and Future Market of Atrial Fibrillation
- Annual cost of treatment for Atrial Fibrillation
- Future Treatment for Atrial Fibrillation
- SWOT Analysis
- Market Research Methodology
- Research Design
- Contact Us
- Disclaimer

List of Tables
Table 1: Marketed Anticoagulants and Approval date , 2015
Table 2: Marketed Anticoagulants with dosage Form and Strength , 2015
Table 3: Type of Marketed Anticoagulant drugs, 2015
Table 4: Marketed Anticoagulants, Patent Expiry Timeline, 2015
Table 5: Indication wise number of marketed drugs, 2015
Table 6: Characteristic of new oral anticoagulants compared with warfarin
Table 7: Comparative pharmacology of Warfarin with other drugs
Table 8: Choice of anticoagulant based on patient characteristics
Table 9: Sales of major players in Market, 2015
Table 10: Forecasted Sales of major players in Market, 2015
Table 11: Product stage wise pipeline anticoagulants, 2015
Table 12: Number of Assets in each phase of pipeline, 2015
Table 13: Number of pipeline drugs by Mechanism of Action, 2015
Table 14: Number of pipeline drugs by Route of Administration, 2015
Table 15: Number of pipeline drugs by Molecule Type, 2015
Table 16: Discontinued Drugs, 2015
Table 17: Dormant Drugs, 2015
Table 18: Annual cost of treatment for Atrial Fibrillation
Table 19: Future Treatment for Atrial Fibrillation

List of Figures
Figure 1: Type of Marketed Anticoagulant drugs, 2015
Figure 1: Type of Marketed Anticoagulant drugs, 2015
Figure 1: Marketed Anticoagulants, Patent Expiry Timeline, 2015
Figure 2: Indication wise number of marketed drugs, 2015
Figure 3: Sales of major players in Market, 2015
Figure 4: Forecasted Sales of Major players in Market, 2015
Figure 5: Percentage of Assets in each phase of pipeline, 2015
Figure 6: Percentage of pipeline drugs by Mechanism of Action, 2015
Figure 7: Percentage of pipeline drugs by Route of Administration, 2015
Figure 8: Percentage of pipeline drugs by Molecule Type, 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets

Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Analyze the global market for antithrombotic/anticoagulant drugs and the different segments for treating thrombotic disease. - View competitive analyses of recent developments and ...

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the UK

  • December 2016
    194 pages
  • Therapy  

    Infectious Dise...  

    Eye Disease  

  • United Kingdom  

View report >

Anti-Infective and Therapy Market in the US - Forecast

  • December 2016
    249 pages
  • Anti-Infective  

    Therapy  

    Hormone  

  • United States  

View report >

Therapy Market in the Netherlands

  • November 2016
    88 pages
  • Therapy  

  • Netherlands  

View report >

Related Market Segments :

Anticoagulant

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.